Search for: "Waxman v. Waxman & Associates, Inc."
Results 1 - 20
of 101
Sorted by Relevance
|
Sort by Date
8 May 2021, 10:26 pm
The panel will cover recent developments in the Hatch-Waxman and BPCIA litigation and legislation, in particular, the Federal Circuit decisions in Amgen Inc. v. [read post]
20 Sep 2017, 9:18 am
In the face of this conundrum, the court relied on the Federal Circuit’s recent decision in Acorda Therapeutics Inc. v. [read post]
24 Jan 2012, 6:34 pm
Labs. v. [read post]
24 Jun 2013, 6:08 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
24 Jun 2013, 10:08 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
4 Sep 2012, 7:04 am
Watson Pharmaceuticals, Inc., No. 10-12729 (11th Cir. [read post]
28 Sep 2012, 11:15 am
Nosher is an Associate in the Gibbons Intellectual Property Department. [read post]
27 Jul 2012, 9:30 am
Last year the United States Supreme Court held in Pliva, Inc. v. [read post]
25 Jun 2013, 9:51 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
6 May 2010, 9:43 am
Wyeth, Inc., 601 F.Supp.2d 1262 (W.D.Okla. 2009), which was decided 5 days before Stacel. [read post]
23 Nov 2010, 6:00 am
The Court in Waxman v. [read post]
6 Dec 2013, 1:40 pm
Pfizer Inc., et al. v. [read post]
14 Nov 2013, 7:41 am
Medtronic, Inc., 552 U.S. 312 (2008), Wyeth v. [read post]
15 Aug 2019, 11:16 am
by Dennis Crouch Nalpropion Pharmaceuticals, Inc. v. [read post]
20 Sep 2021, 1:23 am
§ 271(e)(2)(C). [2] AbbVie Inc. v. [read post]
20 Sep 2021, 1:23 am
§ 271(e)(2)(C). [2] AbbVie Inc. v. [read post]
24 Jan 2011, 3:15 pm
Actavis, Inc., 593 F.3d 428 (5th Cir. 2010) and Mensing v. [read post]
12 Apr 2012, 6:25 pm
Hospira, Inc. et al., No. 2011-1018 (Fed. [read post]
22 Feb 2012, 10:21 am
King Drug Co. of Florence, Inc. v. [read post]
6 Sep 2011, 1:10 pm
Classen Immunotherapies, Inc. v. [read post]
